CAPRICOR THERAPEUTICS, INC. Retained Earnings
CAPRICOR THERAPEUTICS, INC. (CAPR) had Retained Earnings of -$379.55 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-14
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$379.55M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$338.82M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$304.88M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$274.71M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$379.55M 10-Q · filed 2026-08-14 |
| 2026-03-31 | -$338.82M 10-Q · filed 2026-05-13 |
| 2025-12-31 | -$304.88M 10-Q · filed 2026-08-14 |
| 2025-09-30 | -$274.71M 10-Q · filed 2025-11-10 |
| 2025-06-30 | -$250.14M 10-Q · filed 2025-08-11 |
| 2025-03-31 | -$224.23M 10-Q · filed 2025-05-14 |
| 2024-12-31 | -$199.83M 10-K · filed 2026-03-17 |
| 2024-09-30 | -$192.72M 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$180.16M 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$169.16M 10-Q · filed 2024-05-14 |
| 2023-12-31 | -$159.37M 10-K · filed 2025-03-26 |
| 2023-09-30 | -$158.61M 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$152.21M 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$144.85M 10-Q · filed 2023-05-12 |
| 2022-12-31 | -$137.08M 10-K · filed 2024-03-11 |
| 2022-09-30 | -$129.36M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$122.99M 10-Q · filed 2022-08-12 |
| 2022-03-31 | -$115.88M 10-Q · filed 2022-05-11 |
| 2021-12-31 | -$108.06M 10-K · filed 2023-03-17 |
| 2021-09-30 | -$101.87M 10-Q · filed 2021-11-12 |
| 2021-06-30 | -$97.94M 10-Q · filed 2021-08-13 |
| 2021-03-31 | -$93.19M 10-Q · filed 2021-05-14 |
| 2020-12-31 | -$88.04M 10-K · filed 2022-03-11 |
| 2020-09-30 | -$83.86M 10-Q · filed 2020-11-13 |
| 2020-06-30 | -$79.95M 10-Q · filed 2020-08-10 |
| 2020-03-31 | -$76.47M 10-Q · filed 2020-05-15 |
| 2019-12-31 | -$74.38M 10-K · filed 2021-03-15 |
| 2019-09-30 | -$72.91M 10-Q · filed 2019-11-08 |
| 2019-06-30 | -$71.30M 10-Q · filed 2019-08-08 |
| 2019-03-31 | -$69.26M 10-Q · filed 2019-05-14 |
| 2018-12-31 | -$66.74M 10-K · filed 2020-03-27 |
| 2018-09-30 | -$63.48M 10-Q · filed 2018-11-14 |
| 2018-06-30 | -$59.34M 10-Q · filed 2018-08-13 |
| 2018-03-31 | -$55.22M 10-Q · filed 2018-05-14 |
| 2017-12-31 | -$51.55M 10-K · filed 2019-03-29 |
| 2017-09-30 | -$63.85M 10-Q · filed 2017-11-14 |
| 2017-06-30 | -$61.12M 10-Q · filed 2017-08-14 |
| 2017-03-31 | -$57.65M 10-Q · filed 2017-05-15 |
| 2016-12-31 | -$53.98M 10-K · filed 2018-03-22 |
| 2016-09-30 | -$49.46M 10-Q · filed 2016-11-14 |
| 2016-06-30 | -$44.13M 10-Q · filed 2016-08-15 |
| 2016-03-31 | -$39.44M 10-Q · filed 2016-05-13 |
| 2015-12-31 | -$35.17M 10-K · filed 2017-03-16 |
| 2015-09-30 | -$31.83M 10-Q · filed 2015-11-13 |
| 2015-06-30 | -$28.91M 10-Q · filed 2015-08-14 |
| 2015-03-31 | -$25.79M 10-Q · filed 2015-05-13 |
| 2014-12-31 | -$22.32M 10-K · filed 2016-03-30 |
| 2013-12-31 | -$16.10M 10-K · filed 2015-03-16 |
| 2013-09-30 | -$48.14M 10-Q · filed 2013-11-14 |
| 2013-06-30 | -$47.79M 10-Q · filed 2013-08-14 |
| 2013-03-31 | -$47.19M 10-Q · filed 2013-06-21 |
| 2012-12-31 | -$46.71M 10-Q · filed 2013-11-14 |
| 2012-09-30 | -$46.51M 10-Q · filed 2013-06-21 |
| 2012-06-30 | -$45.94M 10-Q/A · filed 2012-09-10 |
| 2012-03-31 | -$45.59M 10-Q · filed 2012-05-15 |
| 2011-12-31 | -$44.81M 10-Q · filed 2013-06-21 |
| 2011-09-30 | -$43.15M 10-Q · filed 2011-11-14 |
| 2011-06-30 | -$42.01M 10-Q · filed 2011-08-15 |
| 2010-12-31 | -$39.93M 10-K · filed 2012-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |